FDA Initiative to Assess Safety of Anesthetics and Sedatives in Young Children

The U.S. Food and Drug Administration recently announced agreements with five academic and clinical partners to study the effects of anesthetics and sedatives on the neurocognitive development of infants and young children. The SAFEKIDS Initiative (Safety of Key Inhaled and Intravenous Drugs in Pediatrics) will address major gaps in scientific data about the safe use of anesthetics and sedatives received by millions of children each year.

Click the link below to read the full alert.